The primary aim of the ESOMAR's Questions is to increase transparency and raise awareness of the key issues for researchers to consider when deciding whether an online sampling approach is fit for their purpose.
Humanizing AI: Part 2
Ipsos Update
Discover How Our AI-Powered Platform Transforms Risk Management and Sustainability Compliance
Closing the compliance gap and winning new customers.
Uncover the insights shared by our experts during the ESOMAR 2024 event.
Faster and automated research is becoming increasingly more important. Ipsos answers this need from companies with the Ipsos.Digital platform.
Enter the age of generative AI, ushering in a new era of possibility with the advent of the persona bot – a tool with the potential to revolutionise how pharmaceutical companies activate and leverage segmentation data.
Digital therapeutics (DTx) are emerging as a potential game-changer in healthcare, offering evidence-based digital interventions to help prevent, manage, or treat specific conditions.
There is a growing belief among the public that private corporations should also take responsibility for environmental, social, and governance (ESG) issues; these factors are no longer solely the responsibility of the public and governments. While certain business sectors are perceived as having a heightened obligation to diminish their environmental footprint (particularly energy companies, automobile manufacturers, airlines, and public transport providers), no industry can evade the necessity to act responsibly.